Aller au contenu principal
Profil bibliographique

Yoshiaki Ogawa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

175Publications signalées
2577Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Myeloid Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchMultiple Myeloma Research and TreatmentsGallbladder and Bile Duct Disorders

Les publications récentes

Accès ouvert 2026 article OpenAlex

Successful Pulsed Field Ablation for Paroxysmal Atrial Fibrillation in a Patient with Type 1 von Willebrand Disease under Perioperative Recombinant Human von Willebrand Factor Supplementation

Motoki Endo, Atsuhiko Yagishita, Kazuma Iimura, Aika Iijima et autres

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and a major risk factor for stroke and heart failure. 1 Catheter ablation with pulmonary vein isolation (PVI) is an established rhythm-control strategy for drug-refractory paroxysmal AF. 2 Pulsed field ablation (PFA), …

jp (code pays fourni par la source)

0 citations HeartRhythm Case Reports
Accès ouvert 2026 article OpenAlex

A phase I/II study of tagraxofusp in Japanese patients with blastic plasmacytoid dendritic cell neoplasm

A. Yokota, Wataru Munakata, Toru Kiguchi, Yoshiaki Ogawa et autres

Tagraxofusp (TAG), a first-in-class CD123-targeted therapy, is a recombinant fusion protein of human interleukin-3 conjugated to a truncated diphtheria toxin payload. Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive orphan hematologic cancer with a poor prognosis, and is derived from plasmacytoid …

jp (code pays fourni par la source)

3 citations International Journal of Hematology
2025 article OpenAlex

Cord blood versus bone marrow/peripheral blood stem cell transplantation under reduced-intensity conditioning in high-risk acute myeloid leukemia and myelodysplastic syndromes

Kaito Harada, Shino Iwata, Shunsuke Tomita, Miina Nasukawa et autres

Cord blood transplantation (CBT) is an alternative donor option for patients lacking suitable matched donors, particularly in high-risk acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). We retrospectively analyzed 76 adults undergoing reduced-intensity conditioning allogeneic transplantation using one of five donor types: …

jp (code pays fourni par la source)

0 citations Leukemia & lymphoma/Leukemia and lymphoma
Accès ouvert 2025 article OpenAlex

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial

Lorenzo Falchi, Marcel Nijland, Huiqiang Huang, Kim Linton et autres

Background An unmet need persists for chemotherapy-free regimens that induce durable responses for relapsed or refractory follicular lymphoma. Lenalidomide and rituximab (R 2 ) is an accepted standard of care in this population. The EPCORE FL-1 trial aimed to evaluate the efficacy …

us, nl, cn, gb, au, br, gr, at, es, il, fr, it, nz, hu, cz, ar, kr, jp, dk (code pays fourni par la source)

25 citations The Lancet
Accès ouvert 2025 article OpenAlex

A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL

Jun Takizawa, Isao Yoshida, Yoshiaki Ogawa, Tomomi Toubai et autres

The development of effective and safe therapies for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in Japan remains a key focus of research. We conducted a phase 2, open-label, multicenter, non-comparative study to evaluate the safety and efficacy of fixed-duration venetoclax plus …

jp, us (code pays fourni par la source)

0 citations International Journal of Hematology
Accès ouvert 2025 article OpenAlex

Long-term follow-up after en bloc resection of the distal radius with reconstruction using ulnar translocation

Yoshiaki Ogawa, Hisaki Aiba, Yohei Kawaguchi, Satoshi Yamada et autres

Reconstruction of the distal radius after en bloc bone tumor resection is challenging. Among various surgical reconstruction methods, ulnar translocation is a simple approach that does not require vascular anastomosis, autograft harvesting, or prosthesis preparation. This report describes the 7-year follow-up of …

jp (code pays fourni par la source)

0 citations Case Reports in Plastic Surgery and Hand Surgery
2025 conference-abstract OpenAlex

Monotherapy update from Phase 1 portion in Phase1/2 trial of the menin-MLL inhibitor enzomenib (DSP-5336) in patients with relapsed or refractory acute leukemia

Naval Guastad Daver, Joshua F. Zeidner, Justin M. Watts, Junichiro Yuda et autres

Abstract Introduction: Enzomenib (ENZO, DSP-5336) is an investigational, oral small molecule inhibitor of the menin and KMT2A protein interaction, intentionally designed with different physiochemical properties such as short half-life of 2-5 hours, low lipophilicity and high clearance that may lead to differences …

us, jp, es, it, fr, ca, sg, tw, be (code pays fourni par la source)

14 citations Blood
Accès ouvert 2025 article OpenAlex

Efficacy and safety of bispecific antibodies in multiple myeloma patients with end-stage renal disease undergoing hemodialysis: a case report of elranatamab and a literature review

Daisuke Ogiya, Rikio Suzuki, Shun Goto, Yosuke Nakagawa et autres

Recent advances in multiple myeloma (MM) treatment, including bispecific antibodies (BsAbs), have improved outcomes. Elranatamab, a BsAb targeting B-cell maturation antigen and CD3, has shown efficacy in relapsed/refractory MM (RRMM). However, its use in patients with end-stage renal disease (ESRD) undergoing hemodialysis …

jp (code pays fourni par la source)

5 citations Annals of Hematology
Accès ouvert 2025 article OpenAlex

Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report

Hidetsugu Kawai, Hidehito Fukushima, Yasuhito Nannya, Makoto Onizuka et autres

De novo Ph-positive MDS with the micro BCR::ABL1 (e19a2/p230) transcript is rare. Here, we report a case of MDS with multilineage dysplasia in an 86-year-old woman. Reverse transcription polymerase chain reaction (RT-PCR) showed the following karyotype: 46, XX, t(9;22)(q34.1;q11.2), i(17)(q10) [20], and …

jp (code pays fourni par la source)

0 citations International Journal of Hematology
Accès ouvert 2025 article OpenAlex

Successful Treatment of Chronic Active Epstein-Barr Virus Infection Complicated by Cardiomyopathy in an Adult Patient

Kaito Harada, Shino Iwata, Shinichiro Machida, Daisuke Furuya et autres

Chronic active Epstein-Barr virus infection (CAEBV) is a rare and potentially fatal condition involving EBV-infected T or natural killer cells. We herein report a 46-year-old man with CAEBV complicated by cardiomyopathy. Imaging and a biopsy revealed EBV-positive CD3+ T cell infiltration in …

jp (code pays fourni par la source)

0 citations Internal Medicine
Accès ouvert 2025 article OpenAlex

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study

Nirav Niranjan Shah, Pier Luigi Zinzani, Michael Wang, Sunita Dwivedy Nasta et autres

ABSTRACT: Relapsed/refractory (R/R) follicular lymphoma (FL) is a chronic disease often requiring multiple lines of therapy. Covalent Bruton tyrosine kinase inhibitor (BTKi) monotherapy has resulted in variable response rates, yet patients invariably experience relapse. While newer therapies such as bispecific antibodies and …

us, it, pl, jp, au, fr, ch, gb (code pays fourni par la source)

5 citations Blood Advances
Accès ouvert 2025 article OpenAlex

Treatment burden in patients with paroxysmal nocturnal hemoglobinuria: an in-depth interview survey

Yutaka Ueda, Naoshi Obara, Shikiko Ueno, Masatoshi Sakurai et autres

Paroxysmal nocturnal hemoglobinuria (PNH) is a lifelong, clonal hematologic disease posing life-threatening risks if untreated. The prognosis for PNH has improved with the advent of C5 inhibitors, which are now the standard of care where available. As treatment options continue to expand, …

jp (code pays fourni par la source)

1 citation Annals of Hematology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.